Actualités
Partenariat entre Immune Biosolutions et Johnson & Johnson
Immune Biosolutions (Ibio), a Jlab @ Toronto resident company, today announced a research collaboration and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Jonhson & Johnson. The agreement, facilitated by Johnson & Johnson Innovation LLC, will focus initially on the discovery and development of therapeutic antibodies in oncology. […]